Historie von Umsatz, Gewinn und Cashflow aus den offiziellen Geschäftsberichten.
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare.
Interaktive Charts und vollständige Abschlüsse ansehen → Bewertungsmodell (DCF) →
| Gewinn- und Verlustrechnung | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gesamtumsatz | $282.1B | $275.0B | $247.1B | $195.3B | $180.5B | $174.1B | $160.4B | $153.6B | $48.6B | $41.8B | $39.8B | $37.9B | $34.9B | $32.4B | $29.1B | $21.6B | $21.1B | $18.4B | $19.1B | $17.6B | $16.5B |
| Bruttoergebnis | $24.2B | $26.0B | $26.0B | $25.2B | $23.5B | $23.0B | $24.2B | $25.1B | $16.3B | $14.1B | $13.0B | $12.5B | $11.7B | $32.4B | $29.1B | $21.6B | $21.1B | $18.4B | $19.1B | $17.6B | $16.5B |
| Bruttomarge % | 8.6% | 9.4% | 10.5% | 12.9% | 13.0% | 13.2% | 15.1% | 16.3% | 33.6% | 33.7% | 32.7% | 32.9% | 33.4% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Betriebsergebnis (EBIT) | $9.5B | $9.1B | $9.4B | $8.5B | $8.4B | $7.9B | $8.2B | $8.1B | $4.2B | $3.9B | $3.1B | $12.4B | $11.6B | $32.4B | $2.9B | $1.9B | $1.8B | $1.9B | $382M | $1.6B | $1.7B |
| Operative Marge % | 3.4% | 3.3% | 3.8% | 4.4% | 4.7% | 4.6% | 5.1% | 5.3% | 8.6% | 9.4% | 7.8% | 32.6% | 33.2% | 100.0% | 9.9% | 8.7% | 8.6% | 10.3% | 2.0% | 9.2% | 10.5% |
| Jahresüberschuss | $6.4B | $6.0B | $3.4B | $5.2B | $6.7B | $5.4B | $8.5B | $5.1B | $2.6B | $2.2B | $1.9B | $2.1B | $2.1B | $1.5B | $1.6B | $1.3B | $1.3B | $1.3B | $292M | $1.1B | $1.2B |
| Nettomarge % | 2.3% | 2.2% | 1.4% | 2.6% | 3.7% | 3.1% | 5.3% | 3.3% | 5.4% | 5.3% | 4.7% | 5.5% | 6.0% | 4.6% | 5.6% | 5.8% | 6.1% | 7.1% | 1.5% | 6.3% | 7.0% |
| EBITDA | — | $11.6B | $11.4B | $10.8B | $10.4B | $10.0B | $10.4B | $11.6B | $5.2B | $4.4B | $3.5B | $3.8B | $3.6B | $597M | $560M | $2.5B | $2.3B | $2.3B | $351M | $1.8B | $1.9B |
| Ergebnis je Aktie (EPS) | $24.16 | $22.40 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.69 | $9.17 | $7.19 | $8.04 | $7.83 | $5.18 | $5.61 | $4.59 | $4.65 | $4.73 | $1.05 | $3.94 | $3.43 |
| Ausstehende Aktien (Mio.) | — | 266M | 283M | 297M | 313M | 341M | 368M | 380M | 247M | 244M | 260M | 261M | 269M | 285M | 290M | 274M | 275M | 275M | 279M | 283M | 337M |
Quelle: veröffentlichte Unternehmensberichte (SEC). Bitte prüfen Sie die Zahlen vor Verwendung auf SEC EDGAR.
Bilanzen, Cashflow-Rechnungen, Quartalsdaten und alle Kennzahlen finden Sie im interaktiven Viewer für CI. /companies/us/CI
Die Informationen auf dieser Website dienen ausschließlich Bildungs- und Informationszwecken und stellen keine Anlageberatung dar. Es werden keine Kursziele und keine Anlageurteile veröffentlicht.
About TickerBase · Data methodology & sources · Privacy · Terms